Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Dar Zavain received 88,424 Recursion Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Jun 17, 2026 · Filed Jun 22, 2026

On Jun 17, 2026, Dar Zavain (Director) received 88,424 Recursion Pharmaceuticals, Inc. shares as an award, leaving 235,655 shares. Filed Jun 22, 2026 (Form 4).

Awarded
88,424 shares
Holding after
235,655 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 17, 2026Class A Common StockAward88,424235,655Direct

Source

View original at SEC

Related